DHAI (DIH Holding US) ROIC %: -34.10% (As of Mar. 2025)


What is DIH Holding US ROIC %?

DIH Holding US DHAI ROIC % is -34.10% as of Mar. 2025.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. DIH Holding US's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2025 was -34.10%.

As of today (2026-06-27), DIH Holding US's WACC % is 0.00%. DIH Holding US's ROIC % is 0.00% (calculated using TTM income statement data). DIH Holding US earns returns that do not match up to its cost of capital. It will destroy value as it grows.


DIH Holding US  (OTCPK:DHAI) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, DIH Holding US's WACC % is 0.00%. DIH Holding US's ROIC % is 0.00% (calculated using TTM income statement data). DIH Holding US earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


DIH Holding US ROIC % Related Terms


DIH Holding US ROIC % Historical Data

* Premium members only.

The historical data trend for DIH Holding US's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US ROIC % Chart

DIH Holding US Annual Data
Trend Mar22 Mar23 Mar24 Mar25
ROIC %
-25.98 -0.53 -7.31 -16.86

DIH Holding US Quarterly Data
Mar22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -34.41 -34.10

DHAI vs ABT, SYK, MDT: ROIC % Comparison

For the Medical Devices subindustry, DIH Holding US's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DIH Holding US ROIC % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DIH Holding US's ROIC % distribution charts can be found below:

* The bar in red indicates where DIH Holding US's ROIC % falls into.



DIH Holding US ROIC % Calculation

DIH Holding US's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Mar. 2025 is calculated as:

ROIC % (A: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2024 ) + Invested Capital (A: Mar. 2025 ))/ count )
=-4.864 * ( 1 - 0% )/( (29.201 + 28.497)/ 2 )
=-4.864/28.849
=-16.86 %

where

DIH Holding US's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2025 is calculated as:

ROIC % (Q: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Mar. 2025 ))/ count )
=-12.828 * ( 1 - 18.73% )/( (32.655 + 28.497)/ 2 )
=-10.4253156/30.576
=-34.10 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of -34.10% mean?
DIH Holding US (DHAI) has a ROIC % of -34.10% as of Mar. 2025. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's ROIC % too high?
DIH Holding US's current ROIC % is -34.10%.
How does DIH Holding US's ROIC % compare to ABT and SYK?
DIH Holding US's ROIC % of -34.10% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROIC % is 1.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Medical Devices & Instruments company?
The median ROIC % among Medical Devices & Instruments companies is 1.26, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on DIH Holding US and its competitors. For the Medical Devices & Instruments industry, the median ROIC % is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DIH Holding US's current ROIC % is -34.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current ROIC % of -34.10%. The current ROIC % is -34.10%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For DIH Holding US (DHAI), the current ROIC % is -34.10% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DIH Holding US Business Description

Address 77 Accord Park Drive, Suite D-1, Norwell, MA, USA, 02061
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.